NasdaqGS - Delayed Quote
USD
BlossomHill Therapeutics, Inc. (BLSM)
13.50
+1.15
(+9.31%)
At close: November 6 at 4:00:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AGRAWAL SUNDEEP Director |
Conversion of Exercise of derivative security | Aug 10, 2026 | -- |
| CHEN BIHUA X. Director and Beneficial Owner of more than 10% of a Class of Security |
Purchase | Aug 10, 2026 | -- |
| CUI JINGRONG JEAN Chief Executive Officer |
Conversion of Exercise of derivative security | Aug 10, 2026 | -- |
| GORDON CARL L Director |
Purchase | Aug 10, 2026 | -- |
| KEYES JASON A Chief Financial Officer |
Purchase | Aug 10, 2026 | 700 |
| LI YISHAN Officer, Director and Beneficial Owner |
Conversion of Exercise of derivative security | Aug 10, 2026 | -- |
| LIPTAK VINCENT PAUL General Counsel |
Purchase | Aug 10, 2026 | 134,099 |
| ORBIMED ADVISORS, L.L.C. Unknown |
Purchase | Aug 10, 2026 | -- |
| SCHMID JOHN P Director |
Purchase | Aug 10, 2026 | 6,000 |
